Clinical Trial Update: Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza [Phase 3]

View source ↗

Summary

Phase 3 trial of Cycloferon for post-exposure prophylaxis of influenza and acute respiratory infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Infection

Drugs mentioned

• Cycloferon

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Influenza, Acute Respiratory Infection | Phase 3 | Status: COMPLETED